Literature DB >> 2139054

Disorders of the visual system in Alzheimer's disease.

M F Mendez1, R L Tomsak, B Remler.   

Abstract

Alzheimer's disease (AD) is associated with disturbances in basic visual, complex visual, and oculomotor functions. The broad range of visual system disorders in AD may result from the concentration of neuropathology in visual association cortex and optic nerves in this disease. AD patients and their caregivers frequently report visuospatial difficulties in these patients. Examination of the visual system in AD may reveal visual field deficits, prolonged visual evoked potentials, depressed contrast sensitivities, and abnormal eye movement recordings. Complex visual disturbances include constructional and visuoperceptual abnormalities, spatial agnosia and Balint's syndrome, environmental disorientation, visual agnosia, facial identification problems, and visual hallucinations. The purpose of this article is to review the spectrum of visual system disturbances found in AD and, in particular, to describe the methods used to screen for complex visual abnormalities in these patients.

Entities:  

Mesh:

Year:  1990        PMID: 2139054

Source DB:  PubMed          Journal:  J Clin Neuroophthalmol        ISSN: 0272-846X


  20 in total

Review 1.  Neurovisual rehabilitation: recent developments and future directions.

Authors:  G Kerkhoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-06       Impact factor: 10.154

2.  Bingo! Externally supported performance intervention for deficient visual search in normal aging, Parkinson's disease, and Alzheimer's disease.

Authors:  Thomas M Laudate; Sandy Neargarder; Tracy E Dunne; Karen D Sullivan; Pallavi Joshi; Grover C Gilmore; Tatiana M Riedel; Alice Cronin-Golomb
Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn       Date:  2011-11-09

3.  The neuropsychological and neuroradiological correlates of slowly progressive visual agnosia.

Authors:  Anna Rita Giovagnoli; Anna Aresi; Fabiola Reati; Alice Riva; Clara Gobbo; Alberto Bizzi
Journal:  Neurol Sci       Date:  2009-01-30       Impact factor: 3.307

4.  Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials.

Authors:  F Sartucci; D Borghetti; T Bocci; L Murri; P Orsini; V Porciatti; N Origlia; L Domenici
Journal:  Brain Res Bull       Date:  2010-04-10       Impact factor: 4.077

Review 5.  Sex differences in cognitive impairment in Alzheimer's disease.

Authors:  Keith R Laws; Karen Irvine; Tim M Gale
Journal:  World J Psychiatry       Date:  2016-03-22

6.  Vision-fair neuropsychological assessment in normal aging, Parkinson's disease and Alzheimer's disease.

Authors:  Chelsea K Toner; Bruce E Reese; Sandy Neargarder; Tatiana M Riedel; Grover C Gilmore; Alice Cronin-Golomb
Journal:  Psychol Aging       Date:  2011-12-26

7.  Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis.

Authors:  Victor T T Chan; Zihan Sun; Shumin Tang; Li Jia Chen; Adrian Wong; Clement C Tham; Tien Y Wong; Christopher Chen; M Kamran Ikram; Heather E Whitson; Eleonora M Lad; Vincent C T Mok; Carol Y Cheung
Journal:  Ophthalmology       Date:  2018-08-13       Impact factor: 12.079

8.  Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease.

Authors:  D C Davies; P McCoubrie; B McDonald; K A Jobst
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

9.  Roughness of retinal layers in Alzheimer's disease.

Authors:  Lucía Jáñez-García; Omar Bachtoula; Elena Salobrar-García; Rosa de Hoz; Ana I Ramirez; Pedro Gil; José M Ramirez; Luis Jáñez-Escalada
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

10.  Visual impairment increases the risk of dementia, especially in young males in a 12-year longitudinal follow-up study of a national cohort.

Authors:  Ga-In Lee; Sang Ah Chi; Kyunga Kim; Sang Won Seo; Hee Jin Kim; Tae-Young Chung; Dong Hui Lim
Journal:  Sci Rep       Date:  2021-05-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.